The global electronic lab notebook market size accounted for USD 740.16 million in 2025 and is forecasted to hit around USD 1,221.06 million by 2034, representing a CAGR of 5.72% from 2025 to 2034. The North America market size was estimated at USD 255.19 million in 2024 and is expanding at a CAGR of 5.74% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Million), with 2024 as the base year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Electronic Lab Notebook Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Electronic Lab Notebook Market Revenue and Volume Forecast, by Product
8.1.1. Cross-disciplinary
8.1.1.1. Market Revenue and Volume Forecast
8.1.2. Specific
8.1.2.1. Market Revenue and Volume Forecast
9.1. Electronic Lab Notebook Market Revenue and Volume Forecast, by Delivery Mode
9.1.1. On-Premises
9.1.1.1. Market Revenue and Volume Forecast
9.1.2. Web-hosted/ Cloud-based
9.1.2.1. Market Revenue and Volume Forecast
10.1. Electronic Lab Notebook Market Revenue and Volume Forecast, by License
10.1.1. Proprietary
10.1.1.1. Market Revenue and Volume Forecast
10.1.2. Open
10.1.2.1. Market Revenue and Volume Forecast
11.1. Electronic Lab Notebook Market Revenue and Volume Forecast, by End Use
11.1.1. Life Sciences
11.1.1.1. Market Revenue and Volume Forecast
11.1.2. CROs
11.1.2.1. Market Revenue and Volume Forecast
11.1.3. Chemical Industry
11.1.3.1. Market Revenue and Volume Forecast
11.1.4. F&B and Agriculture
11.1.4.1. Market Revenue and Volume Forecast
11.1.5. Environmental Testing Labs
11.1.5.1. Market Revenue and Volume Forecast
11.1.6. Petrochemical Refineries & Oil and Gas Industry
11.1.6.1. Market Revenue and Volume Forecast
11.1.7. Other Industries
11.1.7.1. Market Revenue and Volume Forecast
12.1. North America
12.1.1. Market Revenue and Volume Forecast, by Product
12.1.2. Market Revenue and Volume Forecast, by Delivery Mode
12.1.3. Market Revenue and Volume Forecast, by License
12.1.4. Market Revenue and Volume Forecast, by End Use
12.1.5. U.S.
12.1.5.1. Market Revenue and Volume Forecast, by Product
12.1.5.2. Market Revenue and Volume Forecast, by Delivery Mode
12.1.5.3. Market Revenue and Volume Forecast, by License
12.1.5.4. Market Revenue and Volume Forecast, by End Use
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Volume Forecast, by Product
12.1.6.2. Market Revenue and Volume Forecast, by Delivery Mode
12.1.6.3. Market Revenue and Volume Forecast, by License
12.1.6.4. Market Revenue and Volume Forecast, by End Use
12.2. Europe
12.2.1. Market Revenue and Volume Forecast, by Product
12.2.2. Market Revenue and Volume Forecast, by Delivery Mode
12.2.3. Market Revenue and Volume Forecast, by License
12.2.4. Market Revenue and Volume Forecast, by End Use
12.2.5. UK
12.2.5.1. Market Revenue and Volume Forecast, by Product
12.2.5.2. Market Revenue and Volume Forecast, by Delivery Mode
12.2.5.3. Market Revenue and Volume Forecast, by License
12.2.5.4. Market Revenue and Volume Forecast, by End Use
12.2.6. Germany
12.2.6.1. Market Revenue and Volume Forecast, by Product
12.2.6.2. Market Revenue and Volume Forecast, by Delivery Mode
12.2.6.3. Market Revenue and Volume Forecast, by License
12.2.6.4. Market Revenue and Volume Forecast, by End Use
12.2.7. France
12.2.7.1. Market Revenue and Volume Forecast, by Product
12.2.7.2. Market Revenue and Volume Forecast, by Delivery Mode
12.2.7.3. Market Revenue and Volume Forecast, by License
12.2.7.4. Market Revenue and Volume Forecast, by End Use
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Volume Forecast, by Product
12.2.8.2. Market Revenue and Volume Forecast, by Delivery Mode
12.2.8.3. Market Revenue and Volume Forecast, by License
12.2.8.4. Market Revenue and Volume Forecast, by End Use
12.3. APAC
12.3.1. Market Revenue and Volume Forecast, by Product
12.3.2. Market Revenue and Volume Forecast, by Delivery Mode
12.3.3. Market Revenue and Volume Forecast, by License
12.3.4. Market Revenue and Volume Forecast, by End Use
12.3.5. India
12.3.5.1. Market Revenue and Volume Forecast, by Product
12.3.5.2. Market Revenue and Volume Forecast, by Delivery Mode
12.3.5.3. Market Revenue and Volume Forecast, by License
12.3.5.4. Market Revenue and Volume Forecast, by End Use
12.3.6. China
12.3.6.1. Market Revenue and Volume Forecast, by Product
12.3.6.2. Market Revenue and Volume Forecast, by Delivery Mode
12.3.6.3. Market Revenue and Volume Forecast, by License
12.3.6.4. Market Revenue and Volume Forecast, by End Use
12.3.7. Japan
12.3.7.1. Market Revenue and Volume Forecast, by Product
12.3.7.2. Market Revenue and Volume Forecast, by Delivery Mode
12.3.7.3. Market Revenue and Volume Forecast, by License
12.3.7.4. Market Revenue and Volume Forecast, by End Use
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Volume Forecast, by Product
12.3.8.2. Market Revenue and Volume Forecast, by Delivery Mode
12.3.8.3. Market Revenue and Volume Forecast, by License
12.3.8.4. Market Revenue and Volume Forecast, by End Use
12.4. MEA
12.4.1. Market Revenue and Volume Forecast, by Product
12.4.2. Market Revenue and Volume Forecast, by Delivery Mode
12.4.3. Market Revenue and Volume Forecast, by License
12.4.4. Market Revenue and Volume Forecast, by End Use
12.4.5. GCC
12.4.5.1. Market Revenue and Volume Forecast, by Product
12.4.5.2. Market Revenue and Volume Forecast, by Delivery Mode
12.4.5.3. Market Revenue and Volume Forecast, by License
12.4.5.4. Market Revenue and Volume Forecast, by End Use
12.4.6. North Africa
12.4.6.1. Market Revenue and Volume Forecast, by Product
12.4.6.2. Market Revenue and Volume Forecast, by Delivery Mode
12.4.6.3. Market Revenue and Volume Forecast, by License
12.4.6.4. Market Revenue and Volume Forecast, by End Use
12.4.7. South Africa
12.4.7.1. Market Revenue and Volume Forecast, by Product
12.4.7.2. Market Revenue and Volume Forecast, by Delivery Mode
12.4.7.3. Market Revenue and Volume Forecast, by License
12.4.7.4. Market Revenue and Volume Forecast, by End Use
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Volume Forecast, by Product
12.4.8.2. Market Revenue and Volume Forecast, by Delivery Mode
12.4.8.3. Market Revenue and Volume Forecast, by License
12.4.8.4. Market Revenue and Volume Forecast, by End Use
12.5. Latin America
12.5.1. Market Revenue and Volume Forecast, by Product
12.5.2. Market Revenue and Volume Forecast, by Delivery Mode
12.5.3. Market Revenue and Volume Forecast, by License
12.5.4. Market Revenue and Volume Forecast, by End Use
12.5.5. Brazil
12.5.5.1. Market Revenue and Volume Forecast, by Product
12.5.5.2. Market Revenue and Volume Forecast, by Delivery Mode
12.5.5.3. Market Revenue and Volume Forecast, by License
12.5.5.4. Market Revenue and Volume Forecast, by End Use
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Volume Forecast, by Product
12.5.6.2. Market Revenue and Volume Forecast, by Delivery Mode
12.5.6.3. Market Revenue and Volume Forecast, by License
12.5.6.4. Market Revenue and Volume Forecast, by End Use
13.1. LabWare
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Preproduction
13.1.4. Recent Initiatives
13.2. SciY
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Preproduction
13.2.4. Recent Initiatives
13.3. Thermo Fisher Scientific Inc.
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial PerProductance
13.3.4. Recent Initiatives
13.4. Benchling.
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial PerProductance
13.4.4. Recent Initiatives
13.5. LabVantage Solutions Inc
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial PerProductance
13.5.4. Recent Initiatives
13.6. Abbott
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial PerProductance
13.6.4. Recent Initiatives
13.7. Abbott
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial PerProductance
13.7.4. Recent Initiatives
13.8. LabLynx LIMS (Laboratory Information Management System)
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial PerProductance
13.8.4. Recent Initiatives
13.9. Agilent Technologies, Inc.
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial PerProductance
13.9.4. Recent Initiatives
13.10. Dassault Systèmes
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial PerProductance
13.10.4. Recent Initiatives
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
15.1. About Us
15.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
Plan your call and get expert insights!
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client